Common Contracts

EX-10.11 27 dex1011.htm MASTER CLOSING AGREEMENT Confidential Treatment Requested by Fluidigm Corporation MASTER CLOSING AGREEMENT By and Among FLUIDIGM CORPORATION, a California corporation, OCULUS PHARMACEUTICALS, INC., a Delaware corporation, and...

Master Closing Agreement • May 5th, 2020 • Alabama

• Contract Type
  Master Closing Agreement
• Filed
  May 5th, 2020
• Jurisdiction
  Alabama

[***] Information has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with respect to the omitted portions.

MASTER CLOSING AGREEMENT By and Among FLUIDIGM CORPORATION, a California corporation, OCULUS PHARMACEUTICALS, INC., a Delaware corporation, and THE UAB RESEARCH FOUNDATION dated March 7, 2003

Master Closing Agreement • December 3rd, 2010 • Fluidigm Corp • Laboratory analytical instruments • Alabama

• Contract Type
  Master Closing Agreement
• Filed
  December 3rd, 2010
• Company
  Fluidigm Corp
• Industry
  Laboratory analytical instruments
• Jurisdiction
  Alabama

THIS MASTER CLOSING AGREEMENT is entered into as of March 7, 2003 by and among FLUIDIGM CORPORATION, a California corporation ( “Fluidigm” ), OCULUS PHARMACEUTICALS, INC., a Delaware corporation ( “Oculus” ), and THE UAB RESEARCH FOUNDATION ( “UABRF” ).